Medical Developments International Limited (ASX:MVP – Get Free Report) insider Christine Emmanuel-Donnelly acquired 26,478 shares of the stock in a transaction on Wednesday, August 28th. The stock was bought at an average price of A$0.38 ($0.26) per share, with a total value of A$10,061.64 ($6,844.65).
Medical Developments International Price Performance
The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.54 and a current ratio of 2.74.
Medical Developments International Company Profile
See Also
- Five stocks we like better than Medical Developments International
- What is a Special Dividend?
- 3 Small Cap Stocks That Insiders Are Buying
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- What Are Trending Stocks? Trending Stocks Explained
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for Medical Developments International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Developments International and related companies with MarketBeat.com's FREE daily email newsletter.